Showing results (1361-1370 of 2,428) with videos related to

Sort By:
Pageof 243
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 9, 2015
The human antibody fragment DIATHIS1 specific for CEACAM1 enhances natural killer cell cytotoxicity against melanoma cell lines in vitroMaria L Dupuis, Valentina Fiori, Alessandra Soriani, et al.
International Journal of Molecular Sciences|July 27, 2022
NK Cells and Other Cytotoxic Innate Lymphocytes in Colorectal Cancer Progression and MetastasisCinzia Fionda, Gianluca Scarno, Helena Stabile, et al.
Cellular Immunology|June 15, 1996
Phospholipase A2 activity and calpactin I levels in rat lymphokine-activated killer cells: correlation with the cytotoxic activityM G Cifone, L Cironi, P Roncaioli, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1989
Ca++ and 1,25(OH)2D3 enhance peritoneal macrophage (PMPhi) antimicrobial functions in CAPDS Carozzi, M G Nasini, C Schelotto, et al.
European Journal of Radiology|March 1, 2020
Computed Tomography Angiography findings can predict massive bleeding in head and neck tumoursAlessandro Cannavale, Mario Corona, Piergiorgio Nardis, et al.
International Journal of Molecular Sciences|November 27, 2019
The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological ImplicationsGaetano Aurilio, Francesco Piva, Matteo Santoni, et al.
Environmental Pollution (Barking, Essex : 1987)|June 17, 2006
Lichen biomonitoring of ammonia emission and nitrogen deposition around a pig stockfarmL Frati, S Santoni, V Nicolardi, et al.
The American Journal of Cardiology|June 1, 1995
Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (diltiazem) (INTERCEPT) Research GroupW E Boden, R Scheldewaert, E G Walters, et al.
Critical Reviews in Oncology/Hematology|August 25, 2014
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinomaFancesco Maria Guida, Matteo Santoni, Alessandro Conti, et al.
World Journal of Urology|May 29, 2016
Stereotactic body radiotherapy in oligometastatic prostate cancer patients with isolated lymph nodes involvement: a two-institution experienceGianluca Ingrosso, Fabio Trippa, Ernesto Maranzano, et al.
Pageof 243